Anandasekar Priyatharicini, Kaliaperumal Thirumal Valavan, Ramasubramanian Swaminathan, Mervin Edwin Fernando
Internal Medicine, Stanley Medical College, Chennai, IND.
Nephrology, Stanley Medical College, Chennai, IND.
Cureus. 2024 Nov 30;16(11):e74865. doi: 10.7759/cureus.74865. eCollection 2024 Nov.
Background Diabetes mellitus (DM) is a prevalent predisposing factor for urinary tract infections (UTIs). Among hospitalized patients with acute pyelonephritis, UTIs are more common, severe, and associated with worse outcomes, particularly in those with type 2 DM. Pyelonephritis in DM patients is more frequently bilateral and linked to greater complications, with 90% of emphysematous pyelonephritis (EMPN) and cystitis cases occurring in diabetic individuals. Objective This study aims to evaluate the clinical and microbiological profiles, treatment outcomes, and complications of acute pyelonephritis in patients with type 2 DM. Methods A six-month prospective observational study was conducted from March 2016 to August 2016 at Stanley Medical College and Hospital, Chennai, India. A total of 102 hospitalized patients presenting with symptoms suggestive of acute pyelonephritis were included. Data were collected using a clinical questionnaire and analyzed using IBM SPSS Statistics for Windows, Version 20.0 (Released 2011; IBM Corp., Armonk, New York, United States). Patients received culture-sensitive antimicrobial therapy, percutaneous drainage, and renal replacement therapy as required. Results Out of 102 patients, 80 (78.4%) had non-emphysematous pyelonephritis (NEMPN), and 22 (21.6%) had EMPN. The mean age was 55.2±10.9 years, with a female predominance of 63 (78.4%) participants. was the most common organism isolated in 70 (68.6%) cases. Renal dysfunction was present in 67 (65.7%) patients, with a higher prevalence in EMPN (22, 100%) compared to NEMPN (45, 56.3%) (p<0.001). Mortality was observed in three (3.9%) patients, and 25 (24.5%) developed de novo or progressive chronic kidney disease. Conclusion Early diagnosis and aggressive management of EMPN in type 2 DM patients improve outcomes. Acute pyelonephritis is predominantly observed in women, with fever and loin pain as the most common symptoms. is the primary pathogen, and renal dysfunction is frequent but often reversible. Mortality is low with appropriate management.
背景 糖尿病(DM)是尿路感染(UTIs)的常见易感因素。在住院的急性肾盂肾炎患者中,UTIs更为常见、严重,且与更差的预后相关,尤其是在2型糖尿病患者中。糖尿病患者的肾盂肾炎更常为双侧性,且与更多并发症相关,90%的气肿性肾盂肾炎(EMPN)和膀胱炎病例发生在糖尿病患者中。目的 本研究旨在评估2型糖尿病患者急性肾盂肾炎的临床和微生物学特征、治疗结果及并发症。方法 2016年3月至2016年8月在印度金奈的斯坦利医学院和医院进行了一项为期6个月的前瞻性观察研究。共纳入102例有急性肾盂肾炎症状的住院患者。使用临床问卷收集数据,并使用IBM SPSS Statistics for Windows 20.0版(2011年发布;IBM公司,美国纽约州阿蒙克)进行分析。患者根据需要接受针对培养结果的抗菌治疗、经皮引流和肾脏替代治疗。结果 102例患者中,80例(78.4%)患有非气肿性肾盂肾炎(NEMPN),22例(21.6%)患有EMPN。平均年龄为55.2±10.9岁,女性占优势,有63例(78.4%)参与者。 是70例(68.6%)病例中分离出的最常见病原体。67例(65.7%)患者存在肾功能不全,与NEMPN(45例,56.3%)相比,EMPN中肾功能不全的患病率更高(22例,100%)(p<0.001)。3例(3.9%)患者死亡,2